Which pharmaceutical giant rebranded its patient support services in 2018 with a new personalized medicine platform that increased medication adherence by over 40% for chronic disease patients?

In the fast-paced world of pharmaceuticals, brand identity can significantly impact market penetration and consumer trust. This trivia question explores how one major pharmaceutical company revolutionized its brand identity to overcome challenges in patient adherence. Understanding the evolution of pharmaceutical branding offers insights into the delicate balance between commercial success and patient-centered healthcare delivery.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Pfizer with its 'Science Will Win' personalized medicine hub
AstraZeneca with its 'AZ&Me' patient support ecosystem
Novartis with its 'Novartis Access' integrated care platform
Merck with its 'Merck Connects' digital therapy companion